Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment

Keywords

Medicine, Hazard ratio, Cohort study, Opiate Substitution Treatment, Cohort

References

• AUDIT - The alcohol use disorders identification test: guidelines for use in primary care.Thomas F. Babor, John Higgins-Biddle, John B. Saunders — 2001
• Methadone Maintenance Treatment and other Opioid Replacement TherapiesJeff WardRichard P MattickWayne Hall — 1997
• UK population norms for EQ-5DPaul Kind, Geoffrey Hardman, Susan Macran — 1999
• Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.J R Robertson, A B Bucknall, P D Welsby — 1986
• Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study.Edna Oppenheimer, Clive Tobutt, Colin Taylor — 1994
• Drug-related mortality and its impact on adult mortality in eight European countries.Anna Maria Bargagli, Matthew Hickman, Marina Davoli — 2006
• After the epidemic: follow up study of HIV seroprevalence and changing patterns of drug use.C.A. Skidmore, Roy Robertson, Angela A. Robertson — 1990
• Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.Roy Robertson, Gillian Raab, Malcolm Bruce — 2006
• Discrete-Time Methods for the Analysis of Event HistoriesPaul D. Allison — 1982
• A 33-year follow-up of narcotics addicts.Yih‐Ing Hser, Valerie Hoffman, Christine E. Grella — 2001
• Estimating the prevalence of ex-injecting drug use in the populationMichael Sweeting, Daniela De Angelis, A. E. Ades — 2009
• Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).Shane Darke, Joanne Ross, Maree Teesson — 2005
• Applied Survival Analysis: Regression Modeling of Time-to-Event DataDavid W. Hosmer, Stanley Lemeshow, Susanne May — 2008
• Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDSLouisa Degenhardt — 2006
• Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort studyColin McCowan, Brian Kidd, Tom Fahey — 2009
• The lure and the loss of harm reduction in UK drug policy and practiceNeil McKeganey — 2006
• Tutorial in biostatistics: competing risks and multi‐state modelsHein Putter, Marta Fiocco, Ronald B. Geskus — 2007
• Heroin dependence in an English town: 33-year follow-upNehkant H. Rathod, W Addenbrooke, Alan Rosenbach — 2005
• Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.Nina Shah, Noya Galai, David D. Celentano — 2006
• Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.Miranda Langendam, G.H.A. van Brussel, Roel A. Coutinho — 2000

Cited by

• The natural history of injecting drug use: a 25-year longitudinal study of a cohort of injecting drug users in inner city DublinFergus Desmond O'Kelly, C. M. O’Kelly — 2012
• Methadone replacement therapy: tried, tested, effective?JR Robertson, AM Daniels — 2012
• The EMCDDA annual report 2010: the state of the drugs problem in Europe.Miguel Ángel Sanjuán — 2010
• Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.Javier Frechillas Camoiras — 2011
• Drugs: breaking the cycle.Brigid Pike — 2013
• Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future InfectionsHayley Bennett, Phil McEwan, Daniel Sugrue — 2015
• Hiv-positiivisten huumeiden käyttäjien kuolleisuusPaula Niemi, Pekka Tuomola, Kaija Seppä — 2013
• Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.Kun‐Chia Chang, Tsung‐Hsueh Lu, Kuan-Ying Lee — 2015
• Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors.Dhanya Nambiar, Paul A. Agius, Mark Stoové — 2015
• Opioid use and risk of liver fibrosis in HIV/hepatitis C virus‐coinfected patients in CanadaLaurence Brunet, EEM Moodie, Joseph Cox — 2016
• Low incidence of hepatitis C virus among prisoners in Scotland.Avril Taylor, Alison Munro, Elizabeth Allen — 2013
• Excess mortality among opioid-using patients treated with oral naltrexone in Australia.Louisa Degenhardt, Sarah Larney, Jo Kimber — 2015
• The increasing mortality burden of liver disease among opioid-dependent people: cohort study.Amy Gibson, Deborah Randall, Louisa Degenhardt — 2011
• Chronic Pain: A Red Herring or Risk Factor in the Management of Patients Receiving Opioid Substitution TherapyBrittany B. Dennis — 2015
• Commentary on Mehta et al. (2012): Natural history of injecting drug use.Matthew Hickman, Peter Vickerman, Louisa Degenhardt — 2012
• Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, IndiaShruti H. Mehta, Darshan Sudarshi, Aylur K. Srikrishnan — 2011
• Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.Peter Vickerman, Natasha K. Martin, Katy Turner — 2012
• The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and WalesDave Marteau, Rebecca S. McDonald, Kamlesh B. Patel — 2015
• Mortality among heroin users and users of other internationally regulated drugs: A 27-year follow-up of users in the Epidemiologic Catchment Area Program household samplesCatalina Lopez‐Quintero, Kimberly B. Roth, William W. Eaton — 2015
• Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.Jo Kimber, Sarah Larney, Matthew Hickman — 2015

Related papers

• Opiate Substitution Treatment Lowers HIV Infection RiskPaul S. Mueller, FACP. FACP. — 2012
• Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4)Anna Hansell, Jennifer Hollowell, Tom Nichols — 1999
• Light-intensity physical activities and mortality in the United States general population and CKD subpopulation.Srinivasan Beddhu, Guo Wei, Robin L. Marcus — 2015
• Pharmacological treatments of opiate dependence.Amine Benyamina, Michel Reynaud, Lisa Blecha — 2011
• Betting on ChangeKenneth M. Carpenter, Huiping Jiang, Maria A. Sullivan — 2009
• Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapyNasir Mohamad, Nor Hidayah Abu Bakar, Nurfadhlina Musa — 2010